Progress Acquires MarkLogic! Learn More

All Posts By

Fiona Ehret-Kayser

In the pharmaceutical industry, even small improvements to streamline R&D processes can lead to substantially higher revenue and lower costs. In this video, Chief Architect, Imran Chaudhri answers some of the most frequently asked questions about the Pharma Research Hub.
Not satisfied with commercially available collaboration tools, AbbVie sought a technology platform that would help reduce noise and advance teamwork within R&D.
MarkLogic and NTT Data recently joined in a Becker's Hospital Review podcast. Check out the highlights from this discussion to learn how companies are partnering to better manage healthcare data.
AbbVie faces its own share of data challenges in R&D. A recent report by IDC offers insight into the issues and the next-generation database technology AbbVie's using to overcome them.
Data silos and fragmented processes hinder drug safety practices for adverse event detection and reporting. Learn how MarkLogic breaks down data silos—enabling a complete view of data across pharmacovigilance operations that accelerates signal detection and simplifies regulatory reporting
Drug manufacturers can achieve end-to-end visibility into fragmented supply chains, maintaining efficient control over products—at less time and cost.
With an immense amount of clinical data readily available for analytics, the challenge is to efficiently integrate disconnected data silos. Learn how data science and digital data technologies are empowering pharmaceutical organizations to bridge the gaps presented by these data silos.
ISPOR Webinar: Bill Fox joins experts from Sanofi, Mount Sinai Health, and KEVA Health to discuss innovations that are breaking down barriers in dealing with diverse real world data.
MarkLogic World 2018: Join experts from Abbvie, LA Care Health Plan, and the OSHPD for insightful advice on top data challenges.
MarkLogic enables Life Sciences companies to integrate all of their disparate data sets, harmonize the data, and discover new relationships among it—making it an ideal database platform for accelerating real world evidence. Learn how a multinational Fortune 50 company achieved time and cost benefits by developing a metadata catalog to more quickly find valuable assets …